Skip to content

Treatment of female pelvic organ prolapse by transvaginal suspension of sacrococcygeal ligament and laparoscopic suspension of iliocephalic ligament: a randomized controlled trial

Treatment of female pelvic organ prolapse by transvaginal suspension of sacrococcygeal ligament and laparoscopic suspension of iliocephalic ligament: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031491
Enrollment
Unknown
Registered
2020-04-02
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Group A:Transvaginal sacrospinous ligament fixation
Group B:Laparoscopic pectopexy

Sponsors

Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. From May 2020 to April 2022, 94 cases of female pelvic organ prolapse are diagnosed and treated in the pelvic floor disease diagnosis and treatment center of the affiliated obstetrics and Gynecology Hospital of Zhejiang University; 2. Patients who have informed consent and will sign the informed consent; 3. Adult female; 4. Patients with symptomatic pelvic prolapse and stage II or above of POP-Q; 5. Patients with poor effect of conservative treatment and willingness to operate; 6. Patients who can be followed up for 2 years.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of pelvic radiotherapy; 2. Patients with prolapse treated by transvaginal mesh; 3. Patients with a history of transvaginal mesh exposure; 4. Women with fertility requirements; pregnant or lactating patients; 5. The patients with pelvic pain caused by pelvic floor muscle spasm were found under basic condition; 6. In addition to the treatment of pop by inserting mesh on the top of the vagina, patients who have plans to put mesh on other parts at the same time (the treatment of urinary incontinence with sling is not an exclusion standard) 7. Patients with long-term use of steroid hormone in immune diseases; 8. Current smokers; 9. Patients with pain syndrome, which may lead to increased sensitivity to pelvic pain (such as fibromyalgia, bladder pain syndrome); 10. Patients who may have malignant tumors; 11. Patients who are too old to tolerate surgery or whose surgical benefits are significantly smaller than surgical trauma; Those who meet one of them are excluded.

Design outcomes

Primary

MeasureTime frame
POP-Q;questionnaire;

Secondary

MeasureTime frame
Muscle strength of pelvic floor;

Countries

China

Contacts

Public ContactXie Zhenwei

Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College

xiezhenwei315@163.com+86 13588030456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026